ARCHIVES

Importation Is Remedy of Last Resort in Effort to Obtain Generic Injectables

This article is from The Cancer Letter archive.

Vol. 38 No. 09 | March 2, 2012

Download PDF Visit The Full Archive

Related Articles

Panel to Hear Innovation Reports

August 26, 1988

Karlan To Succeed Hoskins As Chairman, DOD Ovarian Cancer Program Advisory Panel.

July 27, 2001

Research Suggestions Considered By DCBD Diagnostic Group

July 11, 1980

FDA Commissioner Holds Up IND While Reviewing Toxicology Guidelines

August 14, 1981

Phase III Avastin Trial Fails Primary Endpoints

February 28, 2014

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

December 26, 2014